table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Hereditary Angioedema Market Size Analysis from 2022 to 2027
1.5.1 Global Hereditary Angioedema Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Hereditary Angioedema Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Hereditary Angioedema Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Hereditary Angioedema Industry Impact
Chapter 2 Global Hereditary Angioedema Competition by Types, Applications, and Top Regions and Countries
2.1 Global Hereditary Angioedema (Volume and Value) by Type
2.1.1 Global Hereditary Angioedema Consumption and Market Share by Type (2016-2021)
2.1.2 Global Hereditary Angioedema Revenue and Market Share by Type (2016-2021)
2.2 Global Hereditary Angioedema (Volume and Value) by Application
2.2.1 Global Hereditary Angioedema Consumption and Market Share by Application (2016-2021)
2.2.2 Global Hereditary Angioedema Revenue and Market Share by Application (2016-2021)
2.3 Global Hereditary Angioedema (Volume and Value) by Regions
2.3.1 Global Hereditary Angioedema Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Hereditary Angioedema Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Hereditary Angioedema Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Hereditary Angioedema Consumption by Regions (2016-2021)
4.2 North America Hereditary Angioedema Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Hereditary Angioedema Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Hereditary Angioedema Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Hereditary Angioedema Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Hereditary Angioedema Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Hereditary Angioedema Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Hereditary Angioedema Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Hereditary Angioedema Sales, Consumption, Export, Import (2016-2021)
4.10 South America Hereditary Angioedema Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Hereditary Angioedema Market Analysis
5.1 North America Hereditary Angioedema Consumption and Value Analysis
5.1.1 North America Hereditary Angioedema Market Under COVID-19
5.2 North America Hereditary Angioedema Consumption Volume by Types
5.3 North America Hereditary Angioedema Consumption Structure by Application
5.4 North America Hereditary Angioedema Consumption by Top Countries
5.4.1 United States Hereditary Angioedema Consumption Volume from 2016 to 2021
5.4.2 Canada Hereditary Angioedema Consumption Volume from 2016 to 2021
5.4.3 Mexico Hereditary Angioedema Consumption Volume from 2016 to 2021
Chapter 6 East Asia Hereditary Angioedema Market Analysis
6.1 East Asia Hereditary Angioedema Consumption and Value Analysis
6.1.1 East Asia Hereditary Angioedema Market Under COVID-19
6.2 East Asia Hereditary Angioedema Consumption Volume by Types
6.3 East Asia Hereditary Angioedema Consumption Structure by Application
6.4 East Asia Hereditary Angioedema Consumption by Top Countries
6.4.1 China Hereditary Angioedema Consumption Volume from 2016 to 2021
6.4.2 Japan Hereditary Angioedema Consumption Volume from 2016 to 2021
6.4.3 South Korea Hereditary Angioedema Consumption Volume from 2016 to 2021
Chapter 7 Europe Hereditary Angioedema Market Analysis
7.1 Europe Hereditary Angioedema Consumption and Value Analysis
7.1.1 Europe Hereditary Angioedema Market Under COVID-19
7.2 Europe Hereditary Angioedema Consumption Volume by Types
7.3 Europe Hereditary Angioedema Consumption Structure by Application
7.4 Europe Hereditary Angioedema Consumption by Top Countries
7.4.1 Germany Hereditary Angioedema Consumption Volume from 2016 to 2021
7.4.2 UK Hereditary Angioedema Consumption Volume from 2016 to 2021
7.4.3 France Hereditary Angioedema Consumption Volume from 2016 to 2021
7.4.4 Italy Hereditary Angioedema Consumption Volume from 2016 to 2021
7.4.5 Russia Hereditary Angioedema Consumption Volume from 2016 to 2021
7.4.6 Spain Hereditary Angioedema Consumption Volume from 2016 to 2021
7.4.7 Netherlands Hereditary Angioedema Consumption Volume from 2016 to 2021
7.4.8 Switzerland Hereditary Angioedema Consumption Volume from 2016 to 2021
7.4.9 Poland Hereditary Angioedema Consumption Volume from 2016 to 2021
Chapter 8 South Asia Hereditary Angioedema Market Analysis
8.1 South Asia Hereditary Angioedema Consumption and Value Analysis
8.1.1 South Asia Hereditary Angioedema Market Under COVID-19
8.2 South Asia Hereditary Angioedema Consumption Volume by Types
8.3 South Asia Hereditary Angioedema Consumption Structure by Application
8.4 South Asia Hereditary Angioedema Consumption by Top Countries
8.4.1 India Hereditary Angioedema Consumption Volume from 2016 to 2021
8.4.2 Pakistan Hereditary Angioedema Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Hereditary Angioedema Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Hereditary Angioedema Market Analysis
9.1 Southeast Asia Hereditary Angioedema Consumption and Value Analysis
9.1.1 Southeast Asia Hereditary Angioedema Market Under COVID-19
9.2 Southeast Asia Hereditary Angioedema Consumption Volume by Types
9.3 Southeast Asia Hereditary Angioedema Consumption Structure by Application
9.4 Southeast Asia Hereditary Angioedema Consumption by Top Countries
9.4.1 Indonesia Hereditary Angioedema Consumption Volume from 2016 to 2021
9.4.2 Thailand Hereditary Angioedema Consumption Volume from 2016 to 2021
9.4.3 Singapore Hereditary Angioedema Consumption Volume from 2016 to 2021
9.4.4 Malaysia Hereditary Angioedema Consumption Volume from 2016 to 2021
9.4.5 Philippines Hereditary Angioedema Consumption Volume from 2016 to 2021
9.4.6 Vietnam Hereditary Angioedema Consumption Volume from 2016 to 2021
9.4.7 Myanmar Hereditary Angioedema Consumption Volume from 2016 to 2021
Chapter 10 Middle East Hereditary Angioedema Market Analysis
10.1 Middle East Hereditary Angioedema Consumption and Value Analysis
10.1.1 Middle East Hereditary Angioedema Market Under COVID-19
10.2 Middle East Hereditary Angioedema Consumption Volume by Types
10.3 Middle East Hereditary Angioedema Consumption Structure by Application
10.4 Middle East Hereditary Angioedema Consumption by Top Countries
10.4.1 Turkey Hereditary Angioedema Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Hereditary Angioedema Consumption Volume from 2016 to 2021
10.4.3 Iran Hereditary Angioedema Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Hereditary Angioedema Consumption Volume from 2016 to 2021
10.4.5 Israel Hereditary Angioedema Consumption Volume from 2016 to 2021
10.4.6 Iraq Hereditary Angioedema Consumption Volume from 2016 to 2021
10.4.7 Qatar Hereditary Angioedema Consumption Volume from 2016 to 2021
10.4.8 Kuwait Hereditary Angioedema Consumption Volume from 2016 to 2021
10.4.9 Oman Hereditary Angioedema Consumption Volume from 2016 to 2021
Chapter 11 Africa Hereditary Angioedema Market Analysis
11.1 Africa Hereditary Angioedema Consumption and Value Analysis
11.1.1 Africa Hereditary Angioedema Market Under COVID-19
11.2 Africa Hereditary Angioedema Consumption Volume by Types
11.3 Africa Hereditary Angioedema Consumption Structure by Application
11.4 Africa Hereditary Angioedema Consumption by Top Countries
11.4.1 Nigeria Hereditary Angioedema Consumption Volume from 2016 to 2021
11.4.2 South Africa Hereditary Angioedema Consumption Volume from 2016 to 2021
11.4.3 Egypt Hereditary Angioedema Consumption Volume from 2016 to 2021
11.4.4 Algeria Hereditary Angioedema Consumption Volume from 2016 to 2021
11.4.5 Morocco Hereditary Angioedema Consumption Volume from 2016 to 2021
Chapter 12 Oceania Hereditary Angioedema Market Analysis
12.1 Oceania Hereditary Angioedema Consumption and Value Analysis
12.2 Oceania Hereditary Angioedema Consumption Volume by Types
12.3 Oceania Hereditary Angioedema Consumption Structure by Application
12.4 Oceania Hereditary Angioedema Consumption by Top Countries
12.4.1 Australia Hereditary Angioedema Consumption Volume from 2016 to 2021
12.4.2 New Zealand Hereditary Angioedema Consumption Volume from 2016 to 2021
Chapter 13 South America Hereditary Angioedema Market Analysis
13.1 South America Hereditary Angioedema Consumption and Value Analysis
13.1.1 South America Hereditary Angioedema Market Under COVID-19
13.2 South America Hereditary Angioedema Consumption Volume by Types
13.3 South America Hereditary Angioedema Consumption Structure by Application
13.4 South America Hereditary Angioedema Consumption Volume by Major Countries
13.4.1 Brazil Hereditary Angioedema Consumption Volume from 2016 to 2021
13.4.2 Argentina Hereditary Angioedema Consumption Volume from 2016 to 2021
13.4.3 Columbia Hereditary Angioedema Consumption Volume from 2016 to 2021
13.4.4 Chile Hereditary Angioedema Consumption Volume from 2016 to 2021
13.4.5 Venezuela Hereditary Angioedema Consumption Volume from 2016 to 2021
13.4.6 Peru Hereditary Angioedema Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Hereditary Angioedema Consumption Volume from 2016 to 2021
13.4.8 Ecuador Hereditary Angioedema Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Hereditary Angioedema Business
14.1 Pharming Group NV
14.1.1 Pharming Group NV Company Profile
14.1.2 Pharming Group NV Hereditary Angioedema Product Specification
14.1.3 Pharming Group NV Hereditary Angioedema Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Shire plc
14.2.1 Shire plc Company Profile
14.2.2 Shire plc Hereditary Angioedema Product Specification
14.2.3 Shire plc Hereditary Angioedema Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 CSL Limited
14.3.1 CSL Limited Company Profile
14.3.2 CSL Limited Hereditary Angioedema Product Specification
14.3.3 CSL Limited Hereditary Angioedema Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 iBio Inc.
14.4.1 iBio Inc. Company Profile
14.4.2 iBio Inc. Hereditary Angioedema Product Specification
14.4.3 iBio Inc. Hereditary Angioedema Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 BioCryst Pharmaceuticals, Inc.
14.5.1 BioCryst Pharmaceuticals, Inc. Company Profile
14.5.2 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product Specification
14.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Ionis Pharmaceuticals, Inc.
14.6.1 Ionis Pharmaceuticals, Inc. Company Profile
14.6.2 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product Specification
14.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Hereditary Angioedema Market Forecast (2022-2027)
15.1 Global Hereditary Angioedema Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Hereditary Angioedema Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Hereditary Angioedema Value and Growth Rate Forecast (2022-2027)
15.2 Global Hereditary Angioedema Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Hereditary Angioedema Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Hereditary Angioedema Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Hereditary Angioedema Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Hereditary Angioedema Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Hereditary Angioedema Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Hereditary Angioedema Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Hereditary Angioedema Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Hereditary Angioedema Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Hereditary Angioedema Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Hereditary Angioedema Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Hereditary Angioedema Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Hereditary Angioedema Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Hereditary Angioedema Consumption Forecast by Type (2022-2027)
15.3.2 Global Hereditary Angioedema Revenue Forecast by Type (2022-2027)
15.3.3 Global Hereditary Angioedema Price Forecast by Type (2022-2027)
15.4 Global Hereditary Angioedema Consumption Volume Forecast by Application (2022-2027)
15.5 Hereditary Angioedema Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
